TD Cowen analysts initiated a new Buy rating for Bio-Techne on July 28, 2025.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen analysts initiated a new Buy rating for Bio-Techne on July 28, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bio-Techne
company
-
TD Cowen
American investment bank
Related events
- TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.
- Investment bank TD Cowen issued buy rating reports and upgraded the stock rating for Danaher, which is tracked by MarketBeat.
- TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- Raymond James Financial and TD Cowen issued rating updates for GDS, alongside an insider transaction disclosure filed with the SEC.
Coverage
Newest first; wire copies grouped- Insider MonkeyBio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen Bio-Techne Corporation (NASDAQ:TECH) is one of the most profitable biotech stocks to invest in now. On July 9, TD Cowen